·For the
treatment of adults with type 2 diabetes
mellitus as an adjunct to diet and exercise.
·In patients insufficiently controlled on their
maximally tolerated dose of metformin alone.
·In combination with other medicinal products
for the treatment of diabetes, in patients insufficiently controlled with
metformin and these medicinal products.
·In patients already being treated with the
combination of empagliflozin and metformin as separate tablets.